https://charts.traderzeitung.de/phases/US50180M1080 string(1422) "{"isin":"US50180M1080","name":"LB Pharmaceuticals Inc","stock_id_xnas":113506860,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":42.96,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":43.79,"close_at":"2026-09-22 15:25:00","complete":true,"perf_pct":1.932},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":42.71,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":-2.4663},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":39.16,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-8.3119},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

LB Pharmaceuticals Aktie News & Nachrichten

[WKN: A41HZS | Symbol: LBRX]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über LB Pharmaceuticals gefunden werden.

LB Pharmaceuticals Nachrichtenticker öffnen

MT Newswires 03.09.2026 14:41 Uhr

LB Pharmaceuticals ernennt Joseph Miller zum CFO

08:38 AM EDT, 03.09.2026 (MT Newswires) -- LB Pharmaceuticals (LBRX) teilte am Donnerstag mit, dass Joseph Miller zum Chief Financial Officer ernannt

MT Newswires 11.08.2026 14:41 Uhr

LB Pharmaceuticals verringert Verlust je Aktie im Q2

08:40 AM EDT, 11.08.2026 (MT Newswires) -- LB Pharmaceuticals (LBRX) meldete am Dienstag, dass sich der Nettoverlust je Aktie im Q2 auf 1,71 $ verring

MT Newswires 11.08.2026 14:10 Uhr

--Earnings Flash (LBRX) LB Pharmaceuticals verzeichnet Q2-Verlust von 1,71 USD je Aktie gegenüber FactSet-Schätzung von 0,81 USD Verlust

MT Newswires 22.07.2026 14:55 Uhr

LB Pharmaceuticals erwartet Topline-Daten der Phase-3-Studie zu Schizophrenie im H1 2027

08:54 AM EDT, 22.07.2026 (MT Newswires) -- LB Pharmaceuticals (LBRX) teilte am Mittwoch mit, dass das Unternehmen nun erwartet, die Topline-Ergebnisse

MT Newswires 21.07.2026 13:38 Uhr

BMO Capital stuft LB Pharmaceuticals mit Outperform und einem Kursziel von $46 ein

07:37 AM EDT, 21.07.2026 (MT Newswires) -- LB Pharmaceuticals, Inc. (LBRX) hat laut einer Umfrage von FactSet unter Analysten ein durchschnittliches R